Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2025-09-12 00:00:00 ET · period of report 2025-09-11 · accession 0001415889-25-024462 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-09-12 | 2025-09-11 | MIRM | BJERKHOLT ERIC | CFO | M - OptEx | — | +18.3K | 49.5K | +59% | — |
| D | 2025-09-12 | 2025-09-12 | MIRM | BJERKHOLT ERIC | CFO | S - Sale+OE | $76.01 | -9,578 | 39.9K | -19% | -$728.0K |
| D | 2025-09-12 | 2025-09-11 | MIRM | BJERKHOLT ERIC | CFO | M - OptEx | $0.00 | -18.3K | 18.3K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-11 | M | A | 18,333 | — | 49,523 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). |
| 2 | Common | Common Stock | 2025-09-12 | S | D | 9,578 | $76.01 | 39,945 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2025-09-11 | M | D | 18,333 | $0.00 | 18,333 | D | — · — to — | 18,333 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). (F3) The restricted stock units vest in a series of three successive equal annual installments beginning on the one-year anniversary of September 11, 2023. |